147 related articles for article (PubMed ID: 5468466)
1. [Long-acting thyroid stimulator (LATS) in thyroid pathology].
Winand R
Rev Med Liege; 1970 Aug; 25(15):478-82. PubMed ID: 5468466
[No Abstract] [Full Text] [Related]
2. [Relation between the exophthalmos producing factor (EPF) and thyroid antibodies].
Kreysing G; Schemmel K; Weisbecker L; Uthgenannt H; Müller W; Kirmse L
Schweiz Med Wochenschr; 1968 Jun; 98(23):852-4. PubMed ID: 5666557
[No Abstract] [Full Text] [Related]
3. Long-acting thyroid stimulator (LATS) in hyperthyroidism and exophthalmos.
Friis T
Dan Med Bull; 1969 Nov; 16(10):294-304. PubMed ID: 5392781
[No Abstract] [Full Text] [Related]
4. [The long acting thyroid stimulator (LATS) in some thyroid diseases. Preliminary results].
Busnardo B; Accordi F; Debiasi S
Acta Isot (Padova); 1968 Oct; 8(2):165-79. PubMed ID: 5761578
[No Abstract] [Full Text] [Related]
5. An improved bio-assay for the determination of long-acting thyroid stimulator (LATS).
Ason EK; Hetzel BS; Good BF; Stenhouse NS
J Clin Endocrinol Metab; 1967 Nov; 27(11):1529-39. PubMed ID: 6075584
[No Abstract] [Full Text] [Related]
6. [The determination of long-acting thyroid stimulator (LATS) in thyroid diseases].
Depisch D; Höfer R; Schatz H
Wien Z Inn Med; 1968; 49(4):121-30. PubMed ID: 5757238
[No Abstract] [Full Text] [Related]
7. Serum thyroglobulin levels in healthy subjects and in patients with thyroid disease.
Torrigiani G; Doniach D; Roitt IM
J Clin Endocrinol Metab; 1969 Mar; 29(3):305-14. PubMed ID: 5773064
[No Abstract] [Full Text] [Related]
8. Plasma thyrotropin (TSH) and long-acting thyroid stimulator (LATS) in patients treated for thyroid carcinoma.
Valenta L; Lemarchand-Béraud T; Vannotti A
Eur J Cancer (1965); 1970 Apr; 6(2):139-43. PubMed ID: 5450187
[No Abstract] [Full Text] [Related]
9. LATS activity, hyperthyroidism, exophthalmos, pretibial myxoedema and acropachy.
Bartholomew C
Br J Clin Pract; 1972 Sep; 26(9):431-3. PubMed ID: 5080337
[No Abstract] [Full Text] [Related]
10. Long-acting thyroid stimulator (LATS) and immunofluorescent studies in patients with pretibial myxoedema.
From E; Diederichsen H; Heydenreich G; Nielsen OS
Dan Med Bull; 1973 Dec; 20(6):188-91. PubMed ID: 4591336
[No Abstract] [Full Text] [Related]
11. Long-acting thyroid stimulator (LATS) in toxic nodular goitre, toxic adenoma and Graves' disease.
Lamberg BA; Gordin A; Viherkoski M; Kvist G
Acta Endocrinol (Copenh); 1969 Oct; 62(2):199-209. PubMed ID: 5394703
[No Abstract] [Full Text] [Related]
12. [Immunological problems in thyroid diseases].
Müller W
Med Klin; 1969 Aug; 64(34):1487-92. PubMed ID: 4900624
[No Abstract] [Full Text] [Related]
13. Transient thyrotoxicosis in an infant delivered to a long-acting thyroid stimulator (LATS)- and LATS protector-negative, thyroid-stimulating antibody-positive woman with Hashimoto's thyroiditis.
Hoffman WH; Sahasrananan P; Ferandos SS; Burek CL; Rose NR
J Clin Endocrinol Metab; 1982 Feb; 54(2):354-6. PubMed ID: 6119322
[TBL] [Abstract][Full Text] [Related]
14. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
Lamberg BA; Gordin A
Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
[No Abstract] [Full Text] [Related]
15. [The effect of immunosuppressive therapy on the long acting thyroid stimulator (LATS) and the clinical picture in patients with localized myxedema and exophthalmus].
Depisch D; Höfer R; Schatz H
Wien Klin Wochenschr; 1969 Jan; 81(1):8-10. PubMed ID: 5818436
[No Abstract] [Full Text] [Related]
16. [Fluctuations of the long-acting thyroid stimulator (LATS) concentration in the blood and its significance in hyperthyroidism].
Noguchi A; Kurihara H; Ozeki Y; Sato S
Nihon Rinsho; 1967 Oct; 25(8):1723-32. PubMed ID: 5626106
[No Abstract] [Full Text] [Related]
17. [Pitfalls in the biological demonstration of the "long acting thyroid stimulator" (LATS)].
Mertz DP; Stelzer M
Schweiz Med Wochenschr; 1968 Sep; 98(38):1471-5. PubMed ID: 5680881
[No Abstract] [Full Text] [Related]
18. [Studies on the problem of a relationship between the occurrence of thyroid antibodies and LATS in hyperthyreosis].
Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
Med Klin; 1966 Dec; 61(52):2062-3. PubMed ID: 5999210
[No Abstract] [Full Text] [Related]
19. [TSH and the "long-acting thyroid stimulator" (LATS) in patients with compensated hyperthyroidism].
zur Mühlen A von ; Hesch RD; von Lilienfeld H; Emrich D
Acta Endocrinol Suppl (Copenh); 1971; 152():86. PubMed ID: 5313711
[No Abstract] [Full Text] [Related]
20. The long-acting thyroid stimulator.
Kriss JP
Calif Med; 1968 Sep; 109(3):202-13. PubMed ID: 4235081
[No Abstract] [Full Text] [Related]
[Next] [New Search]
